Posts - Bill - S 483 Responsibility in Drug Advertising Act of 2025
senate 02/06/2025 - 119th Congress
We are introducing the "Responsibility in Drug Advertising Act of 2025" to amend existing laws and restrict direct-to-consumer drug advertising for the first three years after a drug's approval. Our aim is to prioritize public health by ensuring new medications are thoroughly evaluated for safety before being marketed directly to consumers, unless a waiver is granted by the Secretary based on public health benefits.
Congress.gov
S 483 - Responsibility in Drug Advertising Act of 2025
Views
right-leaning 02/06/2025
Sounds like more government meddling in free enterprise to me!
moderate 02/06/2025
A 3-year breather from drug ads could mean less pressure at the doctor's office.
moderate 02/06/2025
Balance in drug advertising: a centrist's dream come true.
left-leaning 02/06/2025
It's about time we put health over profits and spare us the endless side effect karaoke.
left-leaning 02/06/2025
Direct-to-consumer ads should come with a warning: 'May cause misinformed patients.'
moderate 02/06/2025
If this cuts down on 'Ask your doctor' slogans, I'm cautiously optimistic.
left-leaning 02/06/2025
Finally, a bill that treats Big Pharma like the salesmen they are!
right-leaning 02/06/2025
Why punish drug companies for sharing consumer information?
right-leaning 02/06/2025
Instead of banning ads, how about trusting customers to make smart choices?